What percentage of salivary gland tumors are Warthin's tumors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Warthin Tumor Percentage of Salivary Gland Tumors

Warthin tumor accounts for approximately 4-13% of all salivary gland tumors, though this percentage varies significantly by institution and population studied, with some centers reporting rates as high as 30%. 1, 2, 3

Epidemiologic Data by Study Population

The reported percentage of Warthin tumors among salivary gland neoplasms shows considerable geographic and institutional variation:

  • Standard reported range: 4-13% of all salivary gland tumors 2
  • High-incidence populations: Up to 30% of primary parotid gland tumors in certain U.S. populations (specifically central Pennsylvania) 3
  • Among parotid tumors specifically: Warthin tumor represents the second most common benign parotid neoplasm after pleomorphic adenoma 1, 2

Important Clinical Context

The dramatically higher percentages (23-30%) reported in some U.S. studies correlate strongly with smoking prevalence in those populations. 4, 3 In one institutional series, 94% of Warthin tumor patients had tobacco use history compared to only 60% of patients with other salivary gland tumor types 4. This suggests that population-specific smoking rates significantly influence the relative frequency of Warthin tumors.

Site-Specific Considerations

  • Parotid gland location: Warthin tumor almost exclusively arises in the parotid gland 1, 2
  • Minor salivary gland occurrence: Extremely rare at only 0.1-1.2% of cases 2
  • Submandibular or cervical lymph node: Very infrequent at 0.4-6.9% and 8% respectively 2

Demographic Patterns

The traditional male predominance has evolved over recent decades, with contemporary series showing no significant sex predominance in some populations (22 males vs 20 females in one series) 3. The mean age at diagnosis is 62 years, with rare presentation (<6%) before age 40 2.

Multiplicity Features

  • Multicentric disease: Occurs in 12-20% of patients 2
  • Bilateral involvement: Present in 5-14% of cases 2

These multiplicity rates are clinically relevant when counseling patients and planning surveillance imaging strategies.

References

Research

Imaging of salivary gland tumours.

European journal of radiology, 2008

Research

Warthin tumor arising from the minor salivary gland.

The Journal of craniofacial surgery, 2012

Research

Warthin's tumor. A high incidence and no sex predominance in central Pennsylvania.

Archives of otolaryngology--head & neck surgery, 1992

Research

Warthin's tumor and cigarette smoking.

Southern medical journal, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.